Tegretol 100 mg tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

tegretol 100 mg tabletter

novartis healthcare a/s - carbamazepin - tabletter - 100 mg

Fenemal "DLF" 100 mg tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

fenemal "dlf" 100 mg tabletter

dansk lægemiddelforsyning dlf aps - phenobarbital - tabletter - 100 mg

Testosteron "Medical Valley" 1000 mg/4 ml injektionsvæske, opløsning Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

testosteron "medical valley" 1000 mg/4 ml injektionsvæske, opløsning

medical valley invest ab - testosteronundecanoat - injektionsvæske, opløsning - 1000 mg/4 ml

Abirateron "Sandoz" 1000 mg filmovertrukne tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

abirateron "sandoz" 1000 mg filmovertrukne tabletter

sandoz a/s - abirateronacetat - filmovertrukne tabletter - 1000 mg

Orfiril Long 1000 mg depotgranulat Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

orfiril long 1000 mg depotgranulat

desitin arzneimittel gmbh - natriumvalproat - depotgranulat - 1000 mg

Basocare 1000 mg enterotabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

basocare 1000 mg enterotabletter

fresenius medical care deutschland gmbh - natriumhydrogencarbonat - enterotabletter - 1000 mg

Zoledronsyre "Oresund Pharma" 5 mg/100 ml infusionsvæske, opløsning Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

zoledronsyre "oresund pharma" 5 mg/100 ml infusionsvæske, opløsning

Øresund pharma aps - zoledronsyre, monohydrat - infusionsvæske, opløsning - 5 mg/100 ml

Oroxine 100 mikrogram tabletter Taani - taani - Lægemiddelstyrelsen (Danish Medicines Agency)

oroxine 100 mikrogram tabletter

aspen pharma trading ltd. - levothyroxinnatrium - tabletter - 100 mikrogram

Xtandi Euroopa Liit - taani - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Erleada Euroopa Liit - taani - EMA (European Medicines Agency)

erleada

janssen-cilag international nv - apalutamide - prostatiske neoplasmer - endokrine terapi - erleada er anført:i voksne mænd til behandling af ikke-metastatisk kastration resistent prostatakræft (nmcrpc), som er i høj risiko for at udvikle metastatisk sygdom. hos voksne mænd til behandling af metastatisk hormon-følsomme prostatakræft (mhspc) i kombination med androgen deprivation terapi (adt).